- EGFR Polymorphism as a Predictor of Clinical Outcome in Advanced Lung Cancer Patients Treated with EGFR-TKI
-
Jung M, Cho BC, Lee CH, Park HS, Kang YA, Kim SK, Chang J, Kim DJ, Rha SY, Kim JH, Lee JH
- KMID: 1414254
- Yonsei Med J.
- 2012 Nov;53(6):1128-1135.
- doi: 10.3349/ymj.2012.53.6.1128
PURPOSE: Mutations in the epidermal growth factor receptor (EGFR) have been confirmed as predictors of the efficacy of treatment with EGFR-tyrosine kinase inhibitors (TKIs). We investigated whether polymorphisms of the... -
- CITED
-
- Close
- SHARE
-
- Close
